IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE)
6物価
選択條件:
ブランド
- 富士フイルム和光純薬株式會(huì)社(wako)
- Sigma-Aldrich Japan
パッケージ
- y0001156
- 5mg
- 25mg
- 50mg
- 生産者富士フイルム和光純薬株式會(huì)社(wako)
- 製品番號(hào)W01TRCO859980
- 製品説明
- 英語製品説明1-[(1-Oxopentyl)amino]-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-cyclopentanecarboxamide
- 包裝単位5mg
- 価格¥65100
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式會(huì)社(wako)
- 製品番號(hào)W01USP1347711
- 製品説明Irbesartan Related Compound A (1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide)
- 英語製品説明Irbesartan Related Compound A (1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide)
- 包裝単位25mg
- 価格¥289100
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式會(huì)社(wako)
- 製品番號(hào)W01TRCO859980
- 製品説明
- 英語製品説明1-[(1-Oxopentyl)amino]-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-cyclopentanecarboxamide
- 包裝単位50mg
- 価格¥507600
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號(hào)1347711
- 製品説明 United States Pharmacopeia (USP) Reference Standard
- 英語製品説明Irbesartan Related Compound A United States Pharmacopeia (USP) Reference Standard
- 包裝単位25mg
- 価格¥176000
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號(hào)PHR1958
- 製品説明 Pharmaceutical Secondary Standard; Certified Reference Material
- 英語製品説明Irbesartan Related Compound A Pharmaceutical Secondary Standard; Certified Reference Material
- 包裝単位50mg
- 価格¥108000
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號(hào)Y0001156
- 製品説明 European Pharmacopoeia (EP) Reference Standard
- 英語製品説明Irbesartan impurity A European Pharmacopoeia (EP) Reference Standard
- 包裝単位y0001156
- 価格¥19400
- 更新しました2024-03-01
- 購入
生産者 | 製品番號(hào) | 製品説明 | 包裝単位 | 価格 | 更新時(shí)間 | 購入 |
---|---|---|---|---|---|---|
富士フイルム和光純薬株式會(huì)社(wako) | W01TRCO859980 | 1-[(1-Oxopentyl)amino]-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-cyclopentanecarboxamide |
5mg | ¥65100 | 2024-03-01 | 購入 |
富士フイルム和光純薬株式會(huì)社(wako) | W01USP1347711 | Irbesartan Related Compound A (1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide) Irbesartan Related Compound A (1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide) |
25mg | ¥289100 | 2024-03-01 | 購入 |
富士フイルム和光純薬株式會(huì)社(wako) | W01TRCO859980 | 1-[(1-Oxopentyl)amino]-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-cyclopentanecarboxamide |
50mg | ¥507600 | 2024-03-01 | 購入 |
Sigma-Aldrich Japan | 1347711 | United States Pharmacopeia (USP) Reference Standard Irbesartan Related Compound A United States Pharmacopeia (USP) Reference Standard |
25mg | ¥176000 | 2024-03-01 | 購入 |
Sigma-Aldrich Japan | PHR1958 | Pharmaceutical Secondary Standard; Certified Reference Material Irbesartan Related Compound A Pharmaceutical Secondary Standard; Certified Reference Material |
50mg | ¥108000 | 2024-03-01 | 購入 |
Sigma-Aldrich Japan | Y0001156 | European Pharmacopoeia (EP) Reference Standard Irbesartan impurity A European Pharmacopoeia (EP) Reference Standard |
y0001156 | ¥19400 | 2024-03-01 | 購入 |
プロパティ
比重(密度) :1.26
貯蔵溫度 :2-8°C
溶解性 :DMSO (Slightly), Methanol (Slightly)
酸解離定數(shù)(Pka) :4.16±0.10(Predicted)
貯蔵溫度 :2-8°C
溶解性 :DMSO (Slightly), Methanol (Slightly)
酸解離定數(shù)(Pka) :4.16±0.10(Predicted)
安全情報(bào)
絵表示(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
注意喚起語: | Warning | |||||||||||||||||||||||||||||||||||
危険有害性情報(bào): |
|
|||||||||||||||||||||||||||||||||||
注意書き: |
|
説明
関連商品価格
- イルベサルタン
¥3600-316900 - 2'-[(1H-テトラゾール-5-イル)ビフェニル-4-イル]メタノール
¥63300-497100 - DeMethyl Irbesartan
¥69600-527500